Stockscreener 앱 받기
15.07
0.74%
0.11
시간 외 거래:
15.07
전일 마감가:
$14.96
열려 있는:
$14.9
하루 거래량:
609.47K
Relative Volume:
0.83
시가총액:
$5.34B
수익:
$4.79B
순이익/손실:
$-317.00M
주가수익비율:
-16.56
EPS:
-0.91
순현금흐름:
$-59.00M
1주 성능:
-0.07%
1개월 성능:
+3.01%
6개월 성능:
+3.93%
1년 성능:
-21.88%
1일 변동 폭
$14.87
$15.29
1주일 범위
$14.14
$15.29
52주 변동 폭
$10.45
$21.69
Bausch Lomb Corp Stock (BLCO) Company Profile
명칭
Bausch Lomb Corp
전화
908-541-5456
주소
520 APPLEWOOD CRESCENT, VAUGHAN
BLCO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BLCO
Bausch Lomb Corp
|
15.07 | 5.29B | 4.79B | -317.00M | -59.00M | -0.91 |
|
ISRG
Intuitive Surgical Inc
|
447.23 | 157.45B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
187.17 | 52.74B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
273.73 | 39.69B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
74.51 | 36.64B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
262.33 | 18.72B | 2.96B | 487.70M | 344.00M | 6.68 |
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-02 | 재확인 | H.C. Wainwright | Buy |
| 2025-03-28 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-12-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-15 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2024-07-10 | 개시 | Raymond James | Outperform |
| 2024-05-06 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-12-12 | 개시 | Stifel | Hold |
| 2023-10-03 | 재개 | Evercore ISI | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-03-09 | 개시 | Needham | Hold |
| 2022-12-21 | 개시 | Barclays | Equal Weight |
| 2022-09-12 | 개시 | H.C. Wainwright | Buy |
| 2022-07-26 | 개시 | RBC Capital Mkts | Outperform |
| 2022-06-24 | 개시 | Evercore ISI | Outperform |
| 2022-06-06 | 개시 | Citigroup | Buy |
| 2022-05-31 | 개시 | Deutsche Bank | Hold |
| 2022-05-31 | 개시 | Goldman | Neutral |
| 2022-05-31 | 개시 | Guggenheim | Buy |
| 2022-05-31 | 개시 | JP Morgan | Neutral |
| 2022-05-31 | 개시 | Jefferies | Buy |
| 2022-05-31 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-05-31 | 개시 | Wells Fargo | Overweight |
| 2022-05-11 | 개시 | Cowen | Outperform |
모두보기
Bausch Lomb Corp 주식(BLCO)의 최신 뉴스
Bausch + Lomb Will Release Third-Quarter 2025 Financial Results on Oct. 29 and Hold Investor Day on Nov. 13 - BioSpace
Global Eye Health Leader Bausch + Lomb Announces Q3 Earnings Date and Strategic Investor Day Pipeline Review - Stock Titan
Applying Elliott Wave Theory to Bausch + Lomb Corporation2025 AllTime Highs & Weekly Top Gainers Trade List - newser.com
Why Bausch + Lomb Corporation stock is upgraded to buyPrice Action & AI Driven Stock Movement Reports - newser.com
Can Bausch + Lomb Corporation (S2L) stock deliver strong annual returnsJuly 2025 Trends & Weekly Setup with ROI Potential - newser.com
Bausch + Lomb, Enovis, and Haemonetics Shares Plummet, What You Need To Know - Yahoo Finance
Bausch + Lomb: There Are Better Opportunities Out There (Rating Downgrade) - Seeking Alpha
Trade Recap: Why is Bausch Lomb Corporation stock going upJuly 2025 Market Mood & Safe Capital Growth Tips - خودرو بانک
Goldman Sachs Group Inc. Grows Position in Bausch + Lomb Corporation $BLCO - MarketBeat
Bausch + Lomb Corporation $BLCO Shares Sold by Dynamic Technology Lab Private Ltd - MarketBeat
Bausch + Lomb Corporation (NYSE:BLCO) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Vident Advisory LLC Makes New Investment in Bausch + Lomb Corporation $BLCO - MarketBeat
Aug Shorts: Is Bausch Lomb Corporation exposed to currency risksEarnings Recap Report & Risk Adjusted Buy and Sell Alerts - خودرو بانک
Clearline Capital LP Acquires 247,149 Shares of Bausch + Lomb Corporation $BLCO - MarketBeat
Cubist Systematic Strategies LLC Takes $2.12 Million Position in Bausch + Lomb Corporation $BLCO - MarketBeat
Bausch + Lomb (NYSE:BLCO): Valuation Perspective After New Clinical Data and ASANA Lens Launch - Yahoo Finance
Revolutionary Full Range Vision Lens: Bausch + Lomb's enVista Envy Succeeds in 501-Patient Trial - Stock Titan
Bausch + Lomb (BLCO) Study Shows XIIDRA Eye Drops Improve Comfort For Contact Lens Wearers - Sahm
Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens Wearers - BioSpace
Bausch + Lomb (BLCO) Stock Trades Up, Here Is Why - Yahoo Finance
Little Excitement Around Bausch + Lomb Corporation's (NYSE:BLCO) Revenues - 富途牛牛
Bausch + Lomb Corporation - Baystreet.ca
Complete Custom Contact Lens Portfolio: Bausch + Lomb Launches ASANA for Complex Vision Conditions - Stock Titan
Is Bausch + Lomb Corporation being accumulated by smart money2025 Big Picture & Fast Momentum Entry Tips - خودرو بانک
Can trapped investors hope for a rebound in Bausch + Lomb CorporationTrade Entry Summary & Low Volatility Stock Suggestions - Newser
Is Bausch + Lomb Corporation exposed to currency risksJuly 2025 Movers & Low Risk High Win Rate Stock Picks - خودرو بانک
Nicox Expects to Fully Repay Financial Debts with NCX 470 De-Risked and Globally Licensed - GlobeNewswire Inc.
Is Bausch + Lomb Corporation stock reversal real or fakeWeekly Stock Report & Low Risk High Win Rate Stock Picks - Newser
Is Bausch + Lomb Corporation backed by strong institutional buyingBond Market & Daily Entry Point Alerts - خودرو بانک
Will Bausch + Lomb Corporation continue its uptrend2025 Technical Patterns & Free Community Consensus Stock Picks - Newser
Tools to assess Bausch + Lomb Corporation’s risk profileJuly 2025 Volume & Fast Exit and Entry Strategy Plans - Newser
Is Bausch + Lomb Corporation stock a falling knife or bargain buyEarnings Recap Report & Safe Entry Point Alerts - khodrobank.com
Sector ETF performance correlation with Bausch + Lomb CorporationWeekly Investment Report & Community Verified Swing Trade Signals - Newser
Is Bausch + Lomb Corporation stock bottoming outJuly 2025 Technicals & Fast Moving Stock Watchlists - Newser
Visualizing Bausch + Lomb Corporation stock with heatmapsTrade Performance Summary & AI Optimized Trade Strategies - Newser
Can volume confirm reversal in Bausch + Lomb CorporationEarnings Risk Report & High Return Stock Watch Alerts - Newser
What to expect from Bausch + Lomb Corporation in the next 30 daysWeekly Stock Analysis & AI Enhanced Market Trend Forecasts - Newser
Analyzing Bausch + Lomb Corporation with multi timeframe chartsTake Profit & Risk Controlled Stock Pick Alerts - Newser
Technical signs of recovery in Bausch + Lomb CorporationForecast Cut & Weekly Consistent Profit Watchlists - Newser
Tools to monitor Bausch + Lomb Corporation recovery probabilityVolume Spike & AI Driven Price Forecasts - Newser
Using Bollinger Bands to evaluate Bausch + Lomb CorporationEarnings Recap Summary & AI Enhanced Trading Alerts - Newser
Bausch Lomb Corp (BLCO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.91%
1.74%
자본화:
|
볼륨(24시간):